Back

#RSVvaccine for older #Canadians comes at a cost. https://globalnews.ca/news/10001009/rsv-vaccine-cost-older-canadians-cost/ “On Aug. 4, #HealthCanada approved the first vaccine for #RSV for adults aged 60 and over. The vaccine called #Arexvy, made by drug company GSK, has been shown to be 82-per cent effective at preventing lower respiratory tract disease caused by RSV.

The vaccine is scheduled to roll out sometime in October. It is not publicly funded (in most provinces), meaning most older Canadians may have to pay out of pocket for it.”